Phytohealth Corp (4108) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Phytohealth Corp (4108) has a cash flow conversion efficiency ratio of -0.001x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-2.88 Million ≈ $-90.67K USD) by net assets (NT$2.35 Billion ≈ $74.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 4108 company net worth for the company's overall valuation and market capitalisation.
Phytohealth Corp - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Phytohealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Phytohealth Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Phytohealth Corp ranked by their cash flow conversion efficiency. Explore earnings quality score of Phytohealth Corp to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AimCore Technology Co Ltd
TWO:3615
|
0.041x |
|
CAG Group AB (publ)
ST:CAG
|
-0.019x |
|
Noodles & Company
NASDAQ:NDLS
|
-0.125x |
|
Daejung Chemicals & Metals Co.Ltd
KQ:120240
|
0.027x |
|
Atenor SA
BR:ATEB
|
0.134x |
|
2invest AG
XETRA:2INV
|
N/A |
|
BingEx Ltd
NASDAQ:FLX
|
0.126x |
|
Happy City Holdings Limited Class A Ordinary shares
NASDAQ:HCHL
|
N/A |
Annual Cash Flow Conversion Efficiency for Phytohealth Corp (2005–2025)
The table below shows the annual cash flow conversion efficiency of Phytohealth Corp from 2005 to 2025. View current stock price of Phytohealth Corp for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$2.29 Billion ≈ $72.26 Million |
NT$-39.72 Million ≈ $-1.25 Million |
-0.017x | +18.20% |
| 2024-12-31 | NT$2.37 Billion ≈ $74.62 Million |
NT$-50.13 Million ≈ $-1.58 Million |
-0.021x | +12.24% |
| 2023-12-31 | NT$2.27 Billion ≈ $71.54 Million |
NT$-54.77 Million ≈ $-1.73 Million |
-0.024x | +8.36% |
| 2022-12-31 | NT$2.28 Billion ≈ $71.75 Million |
NT$-59.95 Million ≈ $-1.89 Million |
-0.026x | +7.86% |
| 2021-12-31 | NT$2.39 Billion ≈ $75.25 Million |
NT$-68.24 Million ≈ $-2.15 Million |
-0.029x | +67.11% |
| 2020-12-31 | NT$1.70 Billion ≈ $53.63 Million |
NT$-147.87 Million ≈ $-4.66 Million |
-0.087x | -25.30% |
| 2019-12-31 | NT$1.75 Billion ≈ $55.19 Million |
NT$-121.45 Million ≈ $-3.83 Million |
-0.069x | +4.67% |
| 2018-12-31 | NT$1.94 Billion ≈ $61.27 Million |
NT$-141.44 Million ≈ $-4.46 Million |
-0.073x | +0.29% |
| 2017-12-31 | NT$2.08 Billion ≈ $65.45 Million |
NT$-151.52 Million ≈ $-4.77 Million |
-0.073x | +77.69% |
| 2016-12-31 | NT$2.32 Billion ≈ $72.95 Million |
NT$-756.87 Million ≈ $-23.85 Million |
-0.327x | -472.14% |
| 2015-12-31 | NT$2.30 Billion ≈ $72.36 Million |
NT$-131.22 Million ≈ $-4.13 Million |
-0.057x | -304.42% |
| 2014-12-31 | NT$2.39 Billion ≈ $75.25 Million |
NT$-33.74 Million ≈ $-1.06 Million |
-0.014x | +68.58% |
| 2013-12-31 | NT$2.74 Billion ≈ $86.30 Million |
NT$-123.18 Million ≈ $-3.88 Million |
-0.045x | +23.87% |
| 2012-12-31 | NT$2.78 Billion ≈ $87.67 Million |
NT$-164.37 Million ≈ $-5.18 Million |
-0.059x | +46.05% |
| 2011-12-31 | NT$1.56 Billion ≈ $49.24 Million |
NT$-171.09 Million ≈ $-5.39 Million |
-0.109x | -3.32% |
| 2010-12-31 | NT$1.82 Billion ≈ $57.41 Million |
NT$-193.06 Million ≈ $-6.08 Million |
-0.106x | -98.88% |
| 2009-12-31 | NT$2.01 Billion ≈ $63.36 Million |
NT$-107.15 Million ≈ $-3.38 Million |
-0.053x | -181.31% |
| 2006-12-31 | NT$1.32 Billion ≈ $41.63 Million |
NT$86.57 Million ≈ $2.73 Million |
0.066x | +30.10% |
| 2005-12-31 | NT$1.19 Billion ≈ $37.44 Million |
NT$59.85 Million ≈ $1.89 Million |
0.050x | -- |
About Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more